Catalent
CTLT
#1505
Rank
NZ$20.71 B
Marketcap
$114.12
Share price
0.00%
Change (1 day)
26.93%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -$2.09

According to Catalent's latest financial reports the company's current EPS (TTM) is -$2.32. In 2022 the company made an earnings per share (EPS) of $4.08 a decrease over its 2021 EPS that were of $5.88.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.09-151.27%
2022$4.08-30.58%
2021$5.8879.67%
2020$3.27114.12%
2019$1.53-15%
2018$1.8075.44%
2017$1.02-22.97%
2016$1.33-59.56%
2015$3.29282.05%
2014$0.86-378.2%
2013-$0.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.42-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.35-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.53 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$11.49-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA